JOSE BAUTISTA
MARTINEZ FERRER
Investigador/a en el periodo 2007-2021
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital General Universitario Gregorio Marañón (11)
2021
-
Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies
Revista Espanola de Cardiologia, Vol. 74, Núm. 4, pp. 296-302
2020
-
Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy
ESC Heart Failure, Vol. 7, Núm. 1, pp. 279-283
-
Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection times
Heart, Vol. 106, Núm. 7, pp. 520-526
2019
-
Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices
Journal of Interventional Cardiac Electrophysiology, Vol. 54, Núm. 3, pp. 267-275
-
Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1020-1030
-
Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis
International Journal of Cardiology, Vol. 274, pp. 163-169
2017
-
Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial
JACC: Clinical Electrophysiology, Vol. 3, Núm. 11, pp. 1275-1282
2016
-
Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: Data from the ADVANCE III trial
Europace, Vol. 18, Núm. 11, pp. 1719-1725
2014
2013
-
Novedades en alteraciones del ritmo cardiaco: electrofisiología cardiaca, arritmias y estimulación cardiaca
Revista Espanola de Cardiologia, Vol. 66, Núm. 2, pp. 116-123
2010
-
¿Compensa añadir la resincronización cardiaca al tratamiento farmacológico optimizado en pacientes con insuficiencia cardiaca en España?
Pharmacoeconomics - Spanish Research Articles, Vol. 7, Núm. 1, pp. 13-25